Answers are grounded in this paper and cite their sources.
conditions. In the acute colitis mouse model induced by DSS, the orally administered Ze@SA@AA-G NPs markedly decreased disease activity and body weight loss, restored colon length, and reduced intestinal bleeding. Histological and immunohistochemical assessments showed recovery of crypt architecture, restoration of mucin production by goblet cells, suppression of COX-2, iNOS, TNF-α, NF-κB, and IL-1β expression, and enhanced expression of MUC-2 and Claudin-1. Overall, the Ze@SA@AA-G NP system is a safe and effective nanotherapeutic approach toward the management of ulcerative colitis.
No takes yet. Share an insight, caveat, or question.
Islam et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: